Linked Life Data

21295474

Source:http://linkedlifedata.com/resource/pubmed/id/21295474

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2011-2-21
pubmed:abstractText
3-Amido-4-anilinocinnolines have been identified as potent and highly selective inhibitors of CSF-1R. The synthesis and SAR of these compounds is reported, along with some physical property, pharmacokinetic and kinase selectivity data.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1464-3405
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Ltd. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1382-4
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
3-amido-4-anilinocinnolines as a novel class of CSF-1R inhibitor.
pubmed:affiliation
Cancer Research, AstraZeneca R&D Boston, Waltham, MA 02451, USA. david.scott@astrazeneca.com
pubmed:publicationType
Journal Article